Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion type Assertion NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_head.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion description "[Recently, ETS-related gene (ERG) gene rearrangements, phosphatase tensin homologue (PTEN) deletions and serine protease inhibitor Kazal type 1 (SPINK1) overexpression were investigated as potential markers for molecularly subtyping prostate cancer (PCA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_provenance.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion evidence source_evidence_literature NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_provenance.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion SIO_000772 22260502 NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_provenance.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion wasDerivedFrom befree-2016 NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_provenance.
- NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_assertion wasGeneratedBy ECO_0000203 NP954338.RAUohhFjX-qza6M7aegbAs1eRs6vEy0PslPLlAWZMrkYo130_provenance.